Takeda gets China’s approval for $62 billion Shire purchase

Japan’s Takeda Pharmaceutical Co Ltd said on Friday China’s market regulator had approved its $62 billion acquisition of Shire Plc , bringing it closer to becoming a global top 10 drugmaker.

…read more

Source:: Reuters – Business News

      

Did you enjoy this article? Join our FREE Newsletter!
I agree to have my personal information transfered to MailChimp ( more information )
Join over 100,000 investors and business leaders worldwide. Get the latest actionable business and investing intelligence before the rest of the crowd.
We hate spam. Your email address will not be sold or shared with anyone else.